Impact of patient and provider nudges on addressing herpes zoster vaccine series completion
To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion. Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to rece...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2023-01, Vol.41 (3), p.778-786 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 786 |
|---|---|
| container_issue | 3 |
| container_start_page | 778 |
| container_title | Vaccine |
| container_volume | 41 |
| creator | Gatwood, Justin Brookhart, Andrea Kinney, Olivia Hagemann, Tracy Chiu, Chi-Yang Ramachandran, Sujith Gravlee, Emily Hohmeier, Kenneth |
| description | To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion.
Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to receive timed text messages when the second dose was due and available as part of a quality improvement exercise. Main comparisons were between patients intervened by provider nudge only and those intervened by both provider and patient nudges. Data were assessed by GEE-basedlogistic and linear regression, controlling for available patient- and store-level characteristics, and geospatial analyses.
During the baseline period, 100,627 adults received at least one HZ vaccine dose and 83.9% completed the series within 6 months over 88.6 days (SD: 26.53) on average. In the intervention period, 120,339 adults were vaccinated at least once and series completion was 88.3% (both provider nudges and text messaging) and 85.3% (not texted) during this observation window (both p |
| doi_str_mv | 10.1016/j.vaccine.2022.12.016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2755574932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X22015304</els_id><sourcerecordid>2755574932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-f1b4b59a7f2c16bd49ebb5c69e234352581adfa99b833f55757c80a895df6be93</originalsourceid><addsrcrecordid>eNqFkE1r3DAYhEVJabZpf0KDIJdc7OrTtk6lhCQNBHJJINCDkKXXiZa15Ej2Qvvro2U3PfSSk2B4ZjTvIPSNkpoS2nxf11tjrQ9QM8JYTVld1A9oRbuWV0zS7gitCGtEJSh5PEafc14TQiSn6hM65o1kjSRihX7fjJOxM44DnszsIczYBIenFLfeQcJhcU-QcQzYOJcgZx-e8DOkqYh_Y54LcuiBMyRfVBvHaQOzj-EL-jiYTYavh_cEPVxd3l_8qm7vrm8uft5WVggyVwPtRS-VaQdmadM7oaDvpW0UMC64ZLKjxg1Gqb7jfJCyla3tiOmUdEPTg-In6HyfW1q_LJBnPfpsYbMxAeKSNWtlcQnFWUHP_kPXcUmhtNtRqiWMs12g3FM2xZwTDHpKfjTpj6ZE79bXa324Wu_W15Tpohbf6SF96Udw_1xvcxfgxx6AMsfWQ9LZls0tOJ_AztpF_84Xr6rwmP8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2759702329</pqid></control><display><type>article</type><title>Impact of patient and provider nudges on addressing herpes zoster vaccine series completion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Gatwood, Justin ; Brookhart, Andrea ; Kinney, Olivia ; Hagemann, Tracy ; Chiu, Chi-Yang ; Ramachandran, Sujith ; Gravlee, Emily ; Hohmeier, Kenneth</creator><creatorcontrib>Gatwood, Justin ; Brookhart, Andrea ; Kinney, Olivia ; Hagemann, Tracy ; Chiu, Chi-Yang ; Ramachandran, Sujith ; Gravlee, Emily ; Hohmeier, Kenneth</creatorcontrib><description>To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion.
Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to receive timed text messages when the second dose was due and available as part of a quality improvement exercise. Main comparisons were between patients intervened by provider nudge only and those intervened by both provider and patient nudges. Data were assessed by GEE-basedlogistic and linear regression, controlling for available patient- and store-level characteristics, and geospatial analyses.
During the baseline period, 100,627 adults received at least one HZ vaccine dose and 83.9% completed the series within 6 months over 88.6 days (SD: 26.53) on average. In the intervention period, 120,339 adults were vaccinated at least once and series completion was 88.3% (both provider nudges and text messaging) and 85.3% (not texted) during this observation window (both p < 0.0001). Time between doses was shorter for those who received text messages compared to both the baseline period and those in the intervention period that were not texted (both p < 0.001). Controlling for multiple characteristics, the odds of completion improved in the intervention period compared to baseline (OR: 1.07; 95% CI: 1.033–1.111), but a noticeably higher completion odds was observed amongst patients who received a text message in the intervention period (OR: 1.35; 95% CI: 1.286–1.414). Adjusting for patient and pharmacy factors, those who were texted received their second herpes zoster vaccine dose 8.6 days sooner (95% CI: −9.08 - −8.17, p < 0.0001) compared to those intervened by the provider nudge only.
The combined use of clinical and patient-focused nudges is a simple mechanism by which pharmacies and other health care access points can address the multi-dose vaccine needs of diverse patient populations.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2022.12.016</identifier><identifier>PMID: 36526504</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Activities of daily living ; Adult ; Adult vaccination ; Adults ; Cellular telephones ; Clinical decision making ; Clinical decision support ; Combined vaccines ; Community pharmacy ; Community Pharmacy Services ; Drug stores ; Health care access ; Health Services Accessibility ; Herpes zoster ; Herpes Zoster - prevention & control ; Herpes Zoster Vaccine ; Humans ; Immunization ; Influenza ; Messages ; mHealth ; Older people ; Patients ; Pharmacies ; Quality control ; Quality of life ; Short message service ; Telemedicine ; Vaccination ; Vaccines</subject><ispartof>Vaccine, 2023-01, Vol.41 (3), p.778-786</ispartof><rights>2022 The Authors</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><rights>2022. The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-f1b4b59a7f2c16bd49ebb5c69e234352581adfa99b833f55757c80a895df6be93</citedby><cites>FETCH-LOGICAL-c440t-f1b4b59a7f2c16bd49ebb5c69e234352581adfa99b833f55757c80a895df6be93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2759702329?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36526504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gatwood, Justin</creatorcontrib><creatorcontrib>Brookhart, Andrea</creatorcontrib><creatorcontrib>Kinney, Olivia</creatorcontrib><creatorcontrib>Hagemann, Tracy</creatorcontrib><creatorcontrib>Chiu, Chi-Yang</creatorcontrib><creatorcontrib>Ramachandran, Sujith</creatorcontrib><creatorcontrib>Gravlee, Emily</creatorcontrib><creatorcontrib>Hohmeier, Kenneth</creatorcontrib><title>Impact of patient and provider nudges on addressing herpes zoster vaccine series completion</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion.
Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to receive timed text messages when the second dose was due and available as part of a quality improvement exercise. Main comparisons were between patients intervened by provider nudge only and those intervened by both provider and patient nudges. Data were assessed by GEE-basedlogistic and linear regression, controlling for available patient- and store-level characteristics, and geospatial analyses.
During the baseline period, 100,627 adults received at least one HZ vaccine dose and 83.9% completed the series within 6 months over 88.6 days (SD: 26.53) on average. In the intervention period, 120,339 adults were vaccinated at least once and series completion was 88.3% (both provider nudges and text messaging) and 85.3% (not texted) during this observation window (both p < 0.0001). Time between doses was shorter for those who received text messages compared to both the baseline period and those in the intervention period that were not texted (both p < 0.001). Controlling for multiple characteristics, the odds of completion improved in the intervention period compared to baseline (OR: 1.07; 95% CI: 1.033–1.111), but a noticeably higher completion odds was observed amongst patients who received a text message in the intervention period (OR: 1.35; 95% CI: 1.286–1.414). Adjusting for patient and pharmacy factors, those who were texted received their second herpes zoster vaccine dose 8.6 days sooner (95% CI: −9.08 - −8.17, p < 0.0001) compared to those intervened by the provider nudge only.
The combined use of clinical and patient-focused nudges is a simple mechanism by which pharmacies and other health care access points can address the multi-dose vaccine needs of diverse patient populations.</description><subject>Activities of daily living</subject><subject>Adult</subject><subject>Adult vaccination</subject><subject>Adults</subject><subject>Cellular telephones</subject><subject>Clinical decision making</subject><subject>Clinical decision support</subject><subject>Combined vaccines</subject><subject>Community pharmacy</subject><subject>Community Pharmacy Services</subject><subject>Drug stores</subject><subject>Health care access</subject><subject>Health Services Accessibility</subject><subject>Herpes zoster</subject><subject>Herpes Zoster - prevention & control</subject><subject>Herpes Zoster Vaccine</subject><subject>Humans</subject><subject>Immunization</subject><subject>Influenza</subject><subject>Messages</subject><subject>mHealth</subject><subject>Older people</subject><subject>Patients</subject><subject>Pharmacies</subject><subject>Quality control</subject><subject>Quality of life</subject><subject>Short message service</subject><subject>Telemedicine</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1r3DAYhEVJabZpf0KDIJdc7OrTtk6lhCQNBHJJINCDkKXXiZa15Ej2Qvvro2U3PfSSk2B4ZjTvIPSNkpoS2nxf11tjrQ9QM8JYTVld1A9oRbuWV0zS7gitCGtEJSh5PEafc14TQiSn6hM65o1kjSRihX7fjJOxM44DnszsIczYBIenFLfeQcJhcU-QcQzYOJcgZx-e8DOkqYh_Y54LcuiBMyRfVBvHaQOzj-EL-jiYTYavh_cEPVxd3l_8qm7vrm8uft5WVggyVwPtRS-VaQdmadM7oaDvpW0UMC64ZLKjxg1Gqb7jfJCyla3tiOmUdEPTg-In6HyfW1q_LJBnPfpsYbMxAeKSNWtlcQnFWUHP_kPXcUmhtNtRqiWMs12g3FM2xZwTDHpKfjTpj6ZE79bXa324Wu_W15Tpohbf6SF96Udw_1xvcxfgxx6AMsfWQ9LZls0tOJ_AztpF_84Xr6rwmP8</recordid><startdate>20230116</startdate><enddate>20230116</enddate><creator>Gatwood, Justin</creator><creator>Brookhart, Andrea</creator><creator>Kinney, Olivia</creator><creator>Hagemann, Tracy</creator><creator>Chiu, Chi-Yang</creator><creator>Ramachandran, Sujith</creator><creator>Gravlee, Emily</creator><creator>Hohmeier, Kenneth</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20230116</creationdate><title>Impact of patient and provider nudges on addressing herpes zoster vaccine series completion</title><author>Gatwood, Justin ; Brookhart, Andrea ; Kinney, Olivia ; Hagemann, Tracy ; Chiu, Chi-Yang ; Ramachandran, Sujith ; Gravlee, Emily ; Hohmeier, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-f1b4b59a7f2c16bd49ebb5c69e234352581adfa99b833f55757c80a895df6be93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Activities of daily living</topic><topic>Adult</topic><topic>Adult vaccination</topic><topic>Adults</topic><topic>Cellular telephones</topic><topic>Clinical decision making</topic><topic>Clinical decision support</topic><topic>Combined vaccines</topic><topic>Community pharmacy</topic><topic>Community Pharmacy Services</topic><topic>Drug stores</topic><topic>Health care access</topic><topic>Health Services Accessibility</topic><topic>Herpes zoster</topic><topic>Herpes Zoster - prevention & control</topic><topic>Herpes Zoster Vaccine</topic><topic>Humans</topic><topic>Immunization</topic><topic>Influenza</topic><topic>Messages</topic><topic>mHealth</topic><topic>Older people</topic><topic>Patients</topic><topic>Pharmacies</topic><topic>Quality control</topic><topic>Quality of life</topic><topic>Short message service</topic><topic>Telemedicine</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gatwood, Justin</creatorcontrib><creatorcontrib>Brookhart, Andrea</creatorcontrib><creatorcontrib>Kinney, Olivia</creatorcontrib><creatorcontrib>Hagemann, Tracy</creatorcontrib><creatorcontrib>Chiu, Chi-Yang</creatorcontrib><creatorcontrib>Ramachandran, Sujith</creatorcontrib><creatorcontrib>Gravlee, Emily</creatorcontrib><creatorcontrib>Hohmeier, Kenneth</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gatwood, Justin</au><au>Brookhart, Andrea</au><au>Kinney, Olivia</au><au>Hagemann, Tracy</au><au>Chiu, Chi-Yang</au><au>Ramachandran, Sujith</au><au>Gravlee, Emily</au><au>Hohmeier, Kenneth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of patient and provider nudges on addressing herpes zoster vaccine series completion</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2023-01-16</date><risdate>2023</risdate><volume>41</volume><issue>3</issue><spage>778</spage><epage>786</epage><pages>778-786</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>To determine the combined impact of provider-facing and text message-based, patient nudges on herpes zoster vaccine series completion.
Following a period during which Kroger Health implemented provider facing nudges, select US patients that initiated herpes zoster vaccination were randomized to receive timed text messages when the second dose was due and available as part of a quality improvement exercise. Main comparisons were between patients intervened by provider nudge only and those intervened by both provider and patient nudges. Data were assessed by GEE-basedlogistic and linear regression, controlling for available patient- and store-level characteristics, and geospatial analyses.
During the baseline period, 100,627 adults received at least one HZ vaccine dose and 83.9% completed the series within 6 months over 88.6 days (SD: 26.53) on average. In the intervention period, 120,339 adults were vaccinated at least once and series completion was 88.3% (both provider nudges and text messaging) and 85.3% (not texted) during this observation window (both p < 0.0001). Time between doses was shorter for those who received text messages compared to both the baseline period and those in the intervention period that were not texted (both p < 0.001). Controlling for multiple characteristics, the odds of completion improved in the intervention period compared to baseline (OR: 1.07; 95% CI: 1.033–1.111), but a noticeably higher completion odds was observed amongst patients who received a text message in the intervention period (OR: 1.35; 95% CI: 1.286–1.414). Adjusting for patient and pharmacy factors, those who were texted received their second herpes zoster vaccine dose 8.6 days sooner (95% CI: −9.08 - −8.17, p < 0.0001) compared to those intervened by the provider nudge only.
The combined use of clinical and patient-focused nudges is a simple mechanism by which pharmacies and other health care access points can address the multi-dose vaccine needs of diverse patient populations.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>36526504</pmid><doi>10.1016/j.vaccine.2022.12.016</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2023-01, Vol.41 (3), p.778-786 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2755574932 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Activities of daily living Adult Adult vaccination Adults Cellular telephones Clinical decision making Clinical decision support Combined vaccines Community pharmacy Community Pharmacy Services Drug stores Health care access Health Services Accessibility Herpes zoster Herpes Zoster - prevention & control Herpes Zoster Vaccine Humans Immunization Influenza Messages mHealth Older people Patients Pharmacies Quality control Quality of life Short message service Telemedicine Vaccination Vaccines |
| title | Impact of patient and provider nudges on addressing herpes zoster vaccine series completion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A21%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20patient%20and%20provider%20nudges%20on%20addressing%20herpes%20zoster%20vaccine%20series%20completion&rft.jtitle=Vaccine&rft.au=Gatwood,%20Justin&rft.date=2023-01-16&rft.volume=41&rft.issue=3&rft.spage=778&rft.epage=786&rft.pages=778-786&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2022.12.016&rft_dat=%3Cproquest_cross%3E2755574932%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2759702329&rft_id=info:pmid/36526504&rft_els_id=S0264410X22015304&rfr_iscdi=true |